Bicon Dental Implants — The Original Short Implant Pioneer Since 1985

Quick Facts Premium
Average Cost $2,000
Success Rate 97.5%*
Warranty Lifetime*
Origin United States
Material Surgical-Grade Titanium Alloy (Ti-6Al-4V)
Surface Tech Plateau / Fin design — 30%+ more surface area than screw implants; Integra-Ti™ surface

Bicon Dental Implants, headquartered in Boston, Massachusetts, is the original pioneer of short implants and locking taper technology since 1985. Their unique plateau/fin design and 1.5° locking taper connection set them apart from all other implant systems.

Technical Specifications

Specification Details
Origin United States
Headquarters Boston, Massachusetts, USA
Year Founded 1985
Material Surgical-Grade Titanium Alloy (Ti-6Al-4V)
Surface Technology Plateau / Fin design — 30%+ more surface area than screw implants; Integra-Ti™ surface
Prosthetic Options 360° Abutment positioning (no anti-rotation), Cement-retained, Screw-retained, Overdenture, SHORT® implants (5-8mm)
FDA Status FDA 510(k) Cleared — multiple SHORT® implant sizes from 5.0mm to 8.0mm length; full system clearance
Warranty Lifetime*

Who Should Consider Bicon Dental Implants?

Patients with limited bone height who want to avoid bone grafting, those seeking short implants to avoid the maxillary sinus or inferior alveolar nerve, clinicians who value the unique locking taper connection for zero-gap seal, and patients wanting a US-manufactured premium system with 40 years of proven history.

Compare Bicon Dental Implants Head-to-Head

Check Bicon Dental Implants Implant Cost in Your Area

Explore More

Data Sources

  • * Success Rate Source: 5-year retrospective of Bicon short implants (<8mm): high cumulative survival (DOI: 10.1155/2015/197451, BioMed Res Int 2015). Bicon 6×5.7mm: studied in Gentile et al. 2005 (PMID: 16392351). Unique 360° locking taper: bacterially sealed connection.
  • * Warranty Source: Bicon Dental Implants Warranty: covers fixture against manufacturing defects. US manufacturer (Boston). Terms at bicon.com.
Advertisement
Reviewed by Kevin Luo Health Data Researcher
Advertisement